Use of tyrosine kinase inhibitors for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/517 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2601740

The invention relates to the use of selected EGFR kinase inhibitors, especially selected quinazolines, quinolines, and pyrimidopyrimidines, for treating nasal polyposis and chronic rhinosinusitis.

L'invention concerne l'utilisation d'inhibiteurs de kinase EGFR sélectionnés, notamment de quinazolines, de quinolines et de pyrimido-pyrimidines sélectionnées, pour traiter la polypose nasale et la rhino-sinusite chronique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of tyrosine kinase inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tyrosine kinase inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tyrosine kinase inhibitors for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1630114

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.